학술논문

Abstracts from the 1st JoPPP Conference on Pharmaceutical Policy and Practice: Shah Alam, Malaysia. 28-29 August 2019.
Document Type
Abstract
Source
Journal of Pharmaceutical Policy & Practice. 1/29/2020 Supplement 1, Vol. 13, p1-19. 19p.
Subject
*PHARMACEUTICAL policy
*MEDICAL personnel
*CIPROFLOXACIN
*EFAVIRENZ
*HABIT breaking
*PHYSICIANS
*INFORMATION services
*HEALTH facilities
Language
ISSN
2052-3211
Abstract
The availability of medicine is the main pillar in creating patient satisfaction, doctors and pharmacy staff, so patients will get drugs according to medical needs. Drug emptiness still occurs even though it is small (0.48%), with the length of time the drug emptiness ranges from 1.42, 5.76 and 15.76%. however there is still a lack of drug stocks of 0.36%, 0.45% and 10.48%. Price transparency in healthcare can be defined as readily available information on the price of healthcare services or medicines that, together with other information, helps define the value of those services or medicines.[1] While the policy makers are advised to achieve more transparent prices and contract structures for medicines to address disproportionate price differences within and between countries [2], pharmaceutical industries stakeholders' view on medicine price transparency practice is still lacking. The preliminary findings of the study revealed that pharmacists were involved in improving compliance to prescribed regimen, and accessibility to affordable, quality and cost-effective medications; monitoring patient's treatment; and counseling patients and their caretakers on appropriate and rational drug therapy. Drug dosage adjustment of certain medicines is required in patients with reduced renal function to avoid toxicity, because many of these medicines are eliminated by the kidneys. [Extracted from the article]